Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion

Mucosal Immunology

Volumn 6, Issue 6, 2013, Pages 1119-1130

  Li, D ^a   Hodges, R R ^a   Jiao, J ^a   Carozza, R B ^a   Shatos, M A ^a   Chiang, N ^b   Serhan, C N ^b   Dartt, D A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASPIRIN TRIGGERED RESOLVIN D1; CALCIUM ION; CELL PROTEIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 32; HISTAMINE; HISTAMINE H1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUCIN 5AC; RESOLVIN D1; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL STIMULATION; CELLULAR SECRETION; CONJUNCTIVA; ENZYME ACTIVATION; GOBLET CELL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; MALE; MEDIATOR; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT;

ANIMALS; ASPIRIN; BODILY SECRETIONS; CALCIUM SIGNALING; CELLS, CULTURED; CONJUNCTIVITIS, ALLERGIC; DOCOSAHEXAENOIC ACIDS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GOBLET CELLS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE H1;

EID: 84884551967     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.7     Document Type: Article

References (27)

1. Serhan, C.N. et al. Resolution of inflammation: State of the art, definitions and terms. FASEB J. 21, 325-332 (2007).
2. Nathan, C. & Ding, A. Nonresolving inflammation. Cell 140, 871-882 (2010).
3. Stevenson, W., Chauhan, S.K. & Dana, R. Dry eye disease: An immunemediated ocular surface disorder. Arch. Ophthalmol. 130, 90-100 (2012).
4. Guglielmetti, S., Dart, J.K. & Calder, V. Atopic keratoconjunctivitis and atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 10, 478-485.
5. Serhan, C.N., Chiang, N. & Van Dyke, T.E. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361 (2008).
6. Serhan, C.N. et al. Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025-1037 (2002).
7. Leonardi, A. Allergic Disease of the Conjunctiva and Cornea, in Cornea and External Eye DiseaseReinhard, T. & Larkin, F., eds. (2010) 97-120 (Springer, New York, USA.
8. Hayashi, D. et al. Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion. Invest. Ophthalmol. Vis. Sci. 53, 2993-3003 (2012).
9. Martin, N. et al. Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. PLoS One 7, e435452012).
10. Dartt, D.A. et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J. Immunol. 186, 4455-4466 (2011).
11. Krishnamoorthy, S. et al. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. USA 107, 1660-1665 (2010).
12. Jung, S., Pfeiffer, F. & Deitmer, J.W. Histamine-induced calcium entry in rat cerebellar astrocytes: Evidence for capacitative and non-capacitative mechanisms. J. Physiol. 527 (Part 3), 549-561 (2000).
13. Putney, J.W. Jr. Newmolecular players in capacitative Ca2+ entry. J. Cell. Sci. 120, 1959-1965 (2007).
14. Luo, D., Broad, L.M., Bird, G.S. & Putney, J.W. Jr. Signaling pathways underlying muscarinic receptor-induced [Ca2+]i oscillations in HEK293 cells. J. Biol. Chem. 276, 5613-5621 (2001).
15. Li, D., Carozza, R.B., Shatos, M.A., Hodges, R.R. & Dartt, D.A. Effect of histamine on Ca2+-dependent signaling pathways in rat conjunctival goblet cells. Invest. Ophthalmol. Vis. Sci. 53, 6928-6938 (2012).
16. Hayashi, D. et al. Role of histamine and its receptor subtypes in stimulation of conjunctival goblet cell secretion. Invest. Ophthalmol. Vis. Sci. 53, 2993-3003 (2012).
17. Bento, A.F., Claudino, R.F., Dutra, R.C.,Marcon, R. Calixto, J.B.Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-Triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J. Immunol. 187, 1957-1969 (2011).
18. Jin,Y. et al. Anti-Angiogenesis effect of the novel anti-inflammatory and proresolving lipid mediators. Invest. Ophthalmol. Vis. Sci. 50, 4743-4752 (2009).
19. Rajasagi, N.K. et al. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J. Immunol. 186, 1735-1746 (2011).
20. Zhang, F. et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest. Ophthalmol. Vis. Sci. 51, 5601-5609 (2010).
21. de Paiva, C.S., Schwartz, C.E.,Gjorstrup, P. & Pflugfelder, S.C. Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 2012).
22. Li, N., He, J., Schwartz, C.E., Gjorstrup, P. & Bazan, H.E. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J. Ocul. Pharmacol. Ther. 26, 431-439 (2010).
23. Bielory, L. Ocular toxicity of systemic asthma and allergy treatments. Curr. Allergy Asthma Rep. 6, 299-305 (2006).
24. Jones, R. 3rd & Rhee, D.J. Corticosteroid-induced ocular hypertension and glaucoma: A brief review and update of the literature. Curr. Opin. Ophthalmol. 17, 163-167 (2006).
25. Shatos, M.A. et al. Isolation and characterization of cultured human conjunctival goblet cells. Invest. Ophthalmol. Vis. Sci. 44, 2477-2486 (2003).
26. Shatos, M.A. et al. Isolation, characterization, and propagation of rat conjunctival goblet cells in vitro. Invest. Ophthalmol. Vis. Sci. 42, 1455-1464 (2001).
27. Yang, R., Chiang, N., Oh, S.F. & Serhan, C.N. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr. Protoc. Immunol., Chapter 14, Unit14, 262011).